☰

Seunghee Jo, Ph.D. - Publications

Affiliations: 
2011 Molecular and Cell Biology Brandeis University, Waltham, MA, United States 
Area:
Cell Biology, Oncology
Tree Info Grants Similar researchers PubMed Report error

11 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Goruppi S, Jo SH, Laszlo C, Clocchiatti A, Neel V, Dotto GP. Autophagy Controls CSL/RBPJκ Stability through a p62/SQSTM1-Dependent Mechanism. Cell Reports. 24: 3108-3114.e4. PMID 30231994 DOI: 10.1016/J.Celrep.2018.08.043  0.374
2018 Al Labban D, Jo SH, Ostano P, Saglietti C, Bongiovanni M, Panizzon R, Dotto GP. Notch-effector CSL promotes squamous cell carcinoma by repressing histone demethylase KDM6B. The Journal of Clinical Investigation. PMID 29757189 DOI: 10.1172/Jci96915  0.461
2017 Goruppi S, Procopio MG, Jo S, Clocchiatti A, Neel V, Dotto GP. The ULK3 Kinase Is Critical for Convergent Control of Cancer-Associated Fibroblast Activation by CSL and GLI. Cell Reports. 20: 2468-2479. PMID 28877478 DOI: 10.1016/J.Celrep.2017.08.048  0.394
2017 Kim DE, Procopio MG, Ghosh S, Jo SH, Goruppi S, Magliozzi F, Bordignon P, Neel V, Angelino P, Dotto GP. Convergent roles of ATF3 and CSL in chromatin control of cancer-associated fibroblast activation. The Journal of Experimental Medicine. PMID 28684431 DOI: 10.1084/Jem.20170724  0.421
2016 Jo SH, Kim DE, Clocchiatti A, Dotto GP. PDCD4 is a CSL associated protein with a transcription repressive function in cancer associated fibroblast activation. Oncotarget. PMID 27542230 DOI: 10.18632/Oncotarget.11227  0.406
2016 Song J, Lee J, Kim J, Jo S, Kim YJ, Baek JE, Kwon ES, Lee KP, Yang S, Kwon KS, Kim DU, Kang TH, Park YY, Chang S, Cho HJ, et al. Pancreatic adenocarcinoma up-regulated factor (PAUF) enhances the accumulation and functional activity of myeloid-derived suppressor cells (MDSCs) in pancreatic cancer. Oncotarget. PMID 27322081 DOI: 10.18632/oncotarget.10123  0.372
2015 Procopio MG, Laszlo C, Al Labban D, Kim DE, Bordignon P, Jo SH, Goruppi S, Menietti E, Ostano P, Ala U, Provero P, Hoetzenecker W, Neel V, Kilarski WW, Swartz MA, et al. Combined CSL and p53 downregulation promotes cancer-associated fibroblast activation. Nature Cell Biology. 17: 1193-204. PMID 26302407 DOI: 10.1038/Ncb3228  0.372
2015 Yoon KW, Byun S, Kwon E, Hwang SY, Chu K, Hiraki M, Jo SH, Weins A, Hakroush S, Cebulla A, Sykes DB, Greka A, Mundel P, Fisher DE, Mandinova A, et al. Control of signaling-mediated clearance of apoptotic cells by the tumor suppressor p53. Science (New York, N.Y.). 349. PMID 26228159 DOI: 10.1126/Science.1261669  0.431
2012 Jo SH, Ren R. IRF-4 suppresses BCR/ABL transformation of myeloid cells in a DNA binding-independent manner. The Journal of Biological Chemistry. 287: 1770-8. PMID 22110133 DOI: 10.1074/Jbc.M111.289728  0.599
2011 Jo S, Ren R. IRF-4 Suppresses BCR/ABL Transformation of Myeloid Cells in a DNA-Binding Independent Manner Blood. 118: 1404-1404. DOI: 10.1182/Blood.V118.21.1404.1404  0.603
2010 Jo SH, Schatz JH, Acquaviva J, Singh H, Ren R. Cooperation between deficiencies of IRF-4 and IRF-8 promotes both myeloid and lymphoid tumorigenesis. Blood. 116: 2759-67. PMID 20585039 DOI: 10.1182/Blood-2009-07-234559  0.56
Show low-probability matches.